[
    "<p><strong>A) Retrovirus production</strong></p><p>1.",
    "Plate 1.8 \u00d7 10<sup>6&nbsp;</sup>Plat-GP cells on poly-L-lysine-coated 10 cm dishes and culture them in DMEM containing 8% fetal bovine serum (FBS), 2 mM L-glutamine, and penicillin/streptomycin for 3 days.</p><p>2.&nbsp;Dilute PEI (36 \u00b5L of 1 mg/mL), retroviral plasmid DNA (10 \u00b5g; FOXA3, HNF1A, and HNF6), and VSV-G expression plasmid pCMV-VSV-G (2 \u00b5g) in 1 mL of DMEM and ",
    "Incubate the mixture for 15 minutes at room temperature.</p><p>3.&nbsp;Add the above mixture to the plated Plat-GP cells, drop-by-drop.</p><p>4.&nbsp;After 6 hours of incubation at 37\u00b0C, with 5% CO<sub>2</sub>, ",
    "Re",
    "Place the medium with fresh medium, and continue culturing.</p><p>5.&nbsp;Collect supernatants from the transfected cells 24 hours after medium replacement.",
    "Re",
    "Place the medium with fresh medium, and continue culturing.</p><p>6.&nbsp;Again, ",
    "Collect supernatants from the transfected cells 24 hours after medium replacement.",
    "Filter all the supernatants collected through 0.2 \u00b5m cellulose acetate filters and ",
    "Concentrate them by centrifugation (10,000 \u00d7 g for 16 hours at 4\u00b0C).",
    "Re",
    "Suspend the viral pellets in Hanks\u2019 balanced salt solution (1/140 of initial supernatant volume).</p><p><br></p><p><strong>B) Generation of hiHepPCs from HUVECs</strong></p><p>1.&nbsp;Culture HUVECs in HUVEC medium",
    "[1:1 mixture of Medium 200, supplemented with LSGS, and FibroLife S2 Comp kit].",
    "Following HUVEC expansion in culture, cryopreserve them until they are required.</p><p>2.&nbsp;Thaw the cryopreserved HUVECs, ",
    "Seed them at a density of 1.5 \u00d7 10<sup>4</sup>&nbsp;cells/well in 12-well gelatin-coated plates, and culture them in HUVEC medium.",
    "After 6 hours, ",
    "Re",
    "Place the medium with fresh medium.</p><p>3.&nbsp;Twenty-four hours after seeding (5\u201310% confluency), ",
    "Add the concentrated viral supernatants and 5 \u00b5g/ml protamine sulfate to the culture medium.",
    "After centrifuging at 800 \u00d7 g for 10 minutes, ",
    "Incubate the plates at 37\u00b0C, with 5% CO<sub>2</sub>, for 6 hours.",
    "Then, ",
    "Re",
    "Place the medium with fresh medium and ",
    "Incubate the plates at 37\u00b0C, with 5% CO<sub>2</sub>, for 18 hours.</p><p>4.&nbsp;Retrovirus infection should additionally be conducted 3 times for 3 days.</p><p>5.&nbsp;After the 4th infection, ",
    "Re",
    "Place the medium with hepato-medium (plus), composed of a 1:1 mixture of DMEM and F-12, supplemented with 20% FibroLife S2 Comp kit, 4% FBS, 1 \u00b5g/mL insulin, 10<sup>-7</sup>&nbsp;M dexamethasone, 10 mM nicotinamide, 2 mM L-glutamine, 50 \u00b5M&nbsp;b-mercaptoethanol, 20 ng/mL rhHGF, 1 \u00b5M A8301, 2 \u00b5M SB431542, 5 \u00b5M Y-27632, and penicillin/streptomycin.</p><p>6.&nbsp;After 48 hours, re",
    "Plate the transduced HUVECs on&nbsp;type",
    "I collagen-coated&nbsp;6-well plates, then ",
    "Passage them every 7 days.</p><p><br></p><p><strong>C) Generation of hiHepPCs from HPBECs</strong></p><p>1.&nbsp;HPBECs are obtained from adult human peripheral blood, as described previously<sup>9,10</sup>.</p><p>2.&nbsp;Seed HPBECs at 3 \u00d7 10<sup>4</sup>&nbsp;per well of&nbsp;type",
    "I collagen-coated&nbsp;48-well plates and culture them in HPBEC medium [EGM-2MV BulletKit (Lonza), supplemented with 10% FBS and 50% FibroLife S2 Comp kit]&nbsp;until they reached 20\u201330% confluency.</p><p>3.&nbsp;Perform viral infection (FOXA3, HNF1A, and HNF6, with or without L-MYC), according to the protocol for generating hiHepPCs from HUVECs.</p><p>4.&nbsp;Additionally, ",
    "Perform 7 more retrovirus infections for 7 days.</p><p>5.&nbsp;After the 8th infection, ",
    "Re",
    "Place the medium with a 1:1 mixture of HPBEC medium and hepato-medium (plus).</p><p>6.&nbsp;After 2 days, ",
    "After these colonies appear compact, ",
    "Perform the ",
    "Passage of cells.</p><p><br></p><p><strong>D) Induction of hiHepPC differentiation into hepatocytes</strong></p><p>1.&nbsp;Seed hiHepPCs at 5 \u00d7 10<sup>3</sup>&nbsp;per well of PrimeSurface ultra-low attachment 96-well plates coated with poly 2-hydroxyethyl methacrylate, as described previously<sup>11</sup>&nbsp;and culture them in a medium composed of a 1:1 mixture of DMEM and F-12, supplemented with 1 \u00b5g/mL insulin, 10 mM nicotinamide, 2 mM L-glutamine, 50 \u00b5M&nbsp;b-mercaptoethanol, 20 ng/mL rhHGF, 1 \u00b5M Forskolin, 1 \u00b5M A8301, 20 \u00b5M Y-27632, and penicillin/streptomycin.</p><p>2.&nbsp;hiHepPC aggregates are observed 1 day after 3D culture initiation.",
    "Then, ",
    "Re",
    "Place the medium with fresh medium every 3 days.</p><p><br></p><p><strong>E) Induction of hiHepPC differentiation into cholangiocytes</strong></p><p>1.&nbsp;Mix hiHepPCs (1 \u00d7 10<sup>5</sup>) with 50 \u00b5L of Matrigel and ",
    "Plate them on 24-well plates.</p><p>2.&nbsp;After polymerization of the Matrigel on the HOT PLATE at 37\u00b0C, ",
    "Add an adult human bile duct-derived progenitor cell expansion<sup>&nbsp;</sup>medium<sup>12</sup>&nbsp;(advanced DMEM/F-12, supplemented with 2 mM GlutaMax, 10&nbsp;mM HEPES, N-2 supplement, B-27 supplement, 1 mM N-acetylcysteine, penicillin/streptomycin, 50 ng/mL human recombinant EGF, 100 ng/mL human recombinant Noggin, 500 ng/mL human recombinant R-spondin1, 100 ng/mL human recombinant Wnt3a, 10 \u00b5M Forskolin, 100 ng/ml human FGF10, 10 mM Nicotinamide, 10 nM gastrin, 25 ng/ml rhHGF, and 5 \u00b5M A8301).</p><p>3.&nbsp;After cystic epithelial spheroids are observed in the 3D culture, ",
    "Collect the spheroids with the medium and Matrigel from each well of 24-well plates, ",
    "Transfer them to 15 ml tubes, break the spheroids into small pieces by mechanically pipetting, and ",
    "Wash them with the medium to ",
    "Re",
    "Move the Matrigel.",
    "Divide the broken pieces in half, ",
    "Mix them with new Matrigel, and resume the culturing.</p>"
]